Indian Drugmakers Engineer Hep C Cocktails Impossible in West

Updated on
  • New cocktails could help tackle hepatitis C in poor countries
  • Indian companies eyeing market for genotype 3 of hepatitis C

A scientist for Gilead Sciences works on a potential hepatitis C virus drug candidate.

Photographer: David Paul Morris/Bloomberg

Drugmakers in India are hard at work engineering hepatitis C combination pills impossible in western nations due to patent protections.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.